Loading clinical trials...
Loading clinical trials...
A Pilot, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Effectiveness and Safety of an Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health Among Overall Healthy Participants
Conditions
Interventions
Alpinia galanga formulation
Theacrine formulation
+2 more
Locations
1
United States
Life Extension Clinical Research
Fort Lauderdale, Florida, United States
Start Date
November 2, 2021
Primary Completion Date
May 31, 2022
Completion Date
May 31, 2022
Last Updated
July 28, 2022
NCT06082518
NCT07426991
NCT04542161
NCT03759522
NCT04041154
NCT06441617
Lead Sponsor
Supplement Formulators, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions